1. Home
  2. /
  3. Media and Publications
  4. /
  5. Clients
  6. /
  7. GCA Group Provided Equity...

GCA Group Provided Equity Interest Valuation Service for a Biotech Company for Internal Reference

By December 14, 2022August 4th, 2023No Comments

We are delighted to share with you that we have completed a valuation on equity interest for one of our valuable clients in the field of #biotechnology and #pharmaceutical for helping them through the investment decision-making.

The valuation target company is a Taiwan-based biotech company mainly engaged in the research and development (“R&D”) of medical products, and is specialized in botanical drugs extracted from an herb used as sedative in traditional Chinese medicine and vitreous substitute to eye surgeons.

For this engagement, we performed valuations on equity interest in related to the biotechnology and pharmaceutical businesses which is in R&D stages for our client’s contemplated divestiture and potential separate listing of their subsidiary.

We wish our client every success in the biotechnology and pharmaceutical field in the future!

Leave a Reply